Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 147359-76-0
2. Flibanserin Hcl
3. Flibaserin
4. Flibanserin Hydrochloride [mi]
5. Flibanserin (hydrochloride)
6. 96xtc36k1b
7. 3-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1h-benzimidazol-2-one;hydrochloride
8. 1-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1h-benzo[d]imidazol-2(3h)-one Hydrochloride
9. 2h-benzimidazol-2-one, 1,3-dihydro-1-(2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)-, Hydrochloride
10. 1-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1,3-dihydro-2h-benzo[d]imidazol-2-one Hydrochloride
11. Unii-96xtc36k1b
12. Flibanserinhydrochloride
13. Bimt 17 Hydrochloride
14. Bimt 17bs Hydrochloride
15. Schembl563586
16. Hy-a0095a
17. Amy16553
18. Bcp15754
19. Ex-a2808
20. Xfa35976
21. Mfcd29058559
22. Akos026674090
23. Ds-9963
24. 2h-benzimidazol-2-one, 1,3-dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-, Hydrochloride (1:1)
25. Ac-31715
26. Cs-0027380
27. A925155
28. Q27271942
| Molecular Weight | 426.9 g/mol |
|---|---|
| Molecular Formula | C20H22ClF3N4O |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 426.1434235 g/mol |
| Monoisotopic Mass | 426.1434235 g/mol |
| Topological Polar Surface Area | 38.8 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 550 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Flibanserin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flibanserin Hydrochloride, including repackagers and relabelers. The FDA regulates Flibanserin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flibanserin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flibanserin Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Flibanserin Hydrochloride supplier is an individual or a company that provides Flibanserin Hydrochloride active pharmaceutical ingredient (API) or Flibanserin Hydrochloride finished formulations upon request. The Flibanserin Hydrochloride suppliers may include Flibanserin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Flibanserin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Flibanserin Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Flibanserin Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Flibanserin Hydrochloride GMP manufacturer or Flibanserin Hydrochloride GMP API supplier for your needs.
A Flibanserin Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Flibanserin Hydrochloride's compliance with Flibanserin Hydrochloride specifications and serves as a tool for batch-level quality control.
Flibanserin Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Flibanserin Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Flibanserin Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Flibanserin Hydrochloride EP), Flibanserin Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flibanserin Hydrochloride USP).
LOOKING FOR A SUPPLIER?
